← Eichor
Condition: Transplant Failure Liver Synced from ClinicalTrials.gov · July 28, 2026

Recruiting studies: Transplant Failure Liver

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Serum GLYcomics to Predict Graft Loss and Mortality After Liver Transplantation
Phase N/A · 1 location(s) · University Hospital, Ghent · NCT05866796Leveraging Technology to Improve Medication Adherence in Youth With Kidney or Liver Transplant
NA · 1 location(s) · Johns Hopkins University · NCT05613010Establishing a Reference Framework for Outcomes After Machine-Preserved Liver Transplantation in Europe
Phase N/A · 2 location(s) · University Medical Center Groningen · NCT07585890Abdominal Wall Transplant
NA · 1 location(s) · Duke University · NCT03310905Electronic Archive of Internal Medicine for the Treatment of Severe Organ Failure and Liver Transplantation-MITIGO
Phase N/A · 1 location(s) · IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781502Restrictive Fluid Management In Liver Transplantation (REFIL)
NA · 4 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT07695363Custodiol-N Solution Compared With Custodiol Solution in Organ Transplantation (Kidney, Liver and Pancreas)
Phase 3 · 4 location(s) · Dr. F. Köhler Chemie GmbH · NCT03627013Fecal Microbiota Transplantation for Liver Failure
NA · 1 location(s) · Ningbo Medical Center Lihuili Hospital · NCT05170971Multidimensional Frailty Assessment and Post-Transplant Outcomes in Liver Transplant Candidates
Phase N/A · 1 location(s) · Izmir Bakircay University · NCT07414095Vienna Hypothermic Oxygenated Machine Perfusion Study
Phase N/A · 1 location(s) · Medical University of Vienna · NCT06418165Effect of Preoperative Oral Carbohydrate Loading on Postoperative Outcomes in Liver Transplant Patients
NA · 1 location(s) · Medical University of Warsaw · NCT07519057Functional Assessment in Liver Transplantation
Phase N/A · 12 location(s) · University of California, San Francisco · NCT03228290A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
Phase 2 · 26 location(s) · Deciphera Pharmaceuticals, LLC · NCT06619561Efficacy and Safety of Tranexamic Acid in Adult Liver Transplantation---ESTA Trial
NA · 1 location(s) · RenJi Hospital · NCT07157631Immune Tolerance Induction After Liver Transplantation
Phase 1/Phase 2 · 1 location(s) · University of California, Los Angeles · NCT07269041Micro-encapsulated Hepatocyte Intraperitoneal Transplantation in Liver Failure Adults
Phase 1 · 1 location(s) · RenJi Hospital · NCT05727722VALidation of Imaging-based Liver Biomarkers in PEDiatric Patients
Phase N/A · 1 location(s) · Sahlgrenska University Hospital · NCT07202910Human Umbilical Cord Mesenchymal Stem Cell Transplantation for The Treatment of Acute-on-Chronic Liver Failure
Phase 1/Phase 2 · 1 location(s) · Beijing 302 Hospital · NCT05985863Adverse Outcomes and Mortality in Liver Transplant
NA · 1 location(s) · Mayo Clinic · NCT05477277Magnetic Resonance Elastography as a Method to Estimate Stiffness of Soft Tissues
Phase N/A · 1 location(s) · Arunark Kolipaka · NCT01757730CRISPR-Edited HLA Donor Liver Transplant to Reduce Rejection
Phase 1/Phase 2 · 1 location(s) · AMERICAN ORGAN TRANSPLANT AND CANCER RESEARCH INSTITUTE LLC · NCT07053488Assessment of a Quantra-guided Transfusion Algorithm in Liver Transplantation
NA · 1 location(s) · University Hospital, Toulouse · NCT06749405Disparities Among Liver Transplant Patients
Phase N/A · 1 location(s) · Mayo Clinic · NCT05981196Safety and Efficacy of Fecal Microbiota Transplantation
NA · 1 location(s) · Chinese University of Hong Kong · NCT04014413Faecal Microbiota Transplantation for Liver Cirrhosis
Phase 2/Phase 3 · 1 location(s) · University of Aarhus · NCT04932577The Hepatitis C Transplant Collaborative
Phase N/A · 1 location(s) · Baylor Research Institute · NCT04493385A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative
Phase 3 · 71 location(s) · Pierre Fabre Medicament · NCT03394365CytOSorb TreatMent Of Critically Ill PatientS Registry
Phase N/A · 28 location(s) · CytoSorbents, Inc · NCT05146336Changes in Glucose Tolerance in Patients With Cirrhosis Peri-Liver Transplant
Phase N/A · 1 location(s) · University of Chicago · NCT06950788Dissemination of the Donor Application: Utilizing Social Media to Identify Potential Live Organ Donors
NA · 6 location(s) · Johns Hopkins University · NCT03803423
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.